Insights Into the Dysfunctional Communication Switches Targeting Osteocyte Mechanotransduction and Lacunar–Canalicular Gene Network in Pathogenesis of Osteoarthritis
The Journal of Gene Medicine · 2025-08 · 27 (8)
DOI: 10.1002/jgm.70031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Gene Medicine, online erschienen am 15.08.2025. Verfasst von Shahneela Nusrat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Faculty of Environment and Life, Beijing University of Technology, Beijing, China. Hauptthemen laut MEDLINE: Osteocytes, Mechanotransduction, Cellular, Osteoarthritis, Gene Regulatory Networks. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Osteoarthritis (OA) is a degenerative condition of bone characterized by loss of cartilage, subchondral bone sclerosis, osteophyte growth, synovial inflammation, and influenced by biomechanical loading. The loss of articular cartilage is the primary concern of OA, while subchondral bone plays a crucial role in the integrity of articular cartilage, providing mechanical support and nutrition supply and constantly adapting to the changing biomechanical environment in weight‐bearing joints. Osteocytes, abundant in subchondral bones, sense mechanical loading and control bone adaptive remodeling. Their bodies reside in lacunae and dendritic projections pass through tiny channels named canaliculi, together forming the lacunar–canalicular system (LCS). The disorganization of osteocyte and LCS disrupts communication between osteocytes and other cells; it may contribute to OA initiation and or progression . In this review, insights into osteocyte as the master regulator of mechanosensation and mechanotransduction in bone remodeling by its mechanosensitive structures and dysregulation of osteocyte and LCS‐specific genes in OA are discussed. Finally, this review highlights emerging genetic and molecular targets, including Kindlin‐2, PIEZO1, and Netrin‐1, and discusses their potential in developing novel therapies. By integrating recent advances in mechanobiology, RNA‐based therapies, and nanotechnology, we propose a multi‐targeted approach to improve OA therapeutics. This review provides a comprehensive framework for understanding OA pathogenesis and identifies promising avenues for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Faculty of Environment and Life, Beijing University of Technology, Beijing, China.
- Cancer Imunotherapy Center, Institute of Biomedicine and Biotechnology, Institute of Advance Technology (SIAT), Chinese Academy of Sciences, Shenzhen, China.
ORCID-Profile: Shahneela Nusrat
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Nusrat, S., Din, R. U., Tariq, M. A., & Yang, H. (2025). Insights Into the Dysfunctional Communication Switches Targeting Osteocyte Mechanotransduction and Lacunar–Canalicular Gene Network in Pathogenesis of Osteoarthritis. The Journal of Gene Medicine, 27(8). https://doi.org/10.1002/jgm.70031
Vancouver
Nusrat S, Din RU, Tariq MA, Yang H. Insights Into the Dysfunctional Communication Switches Targeting Osteocyte Mechanotransduction and Lacunar–Canalicular Gene Network in Pathogenesis of Osteoarthritis. The Journal of Gene Medicine. 2025;27(8). doi:10.1002/jgm.70031
BibTeX
@article{Nusrat2025,
author = {Nusrat, Shahneela and Din, Rahman Ud and Tariq, Muhammad Akram and Yang, Haisheng},
title = {Insights Into the Dysfunctional Communication Switches Targeting Osteocyte Mechanotransduction and Lacunar–Canalicular Gene Network in Pathogenesis of Osteoarthritis},
journal = {The Journal of Gene Medicine},
year = {2025},
volume = {27},
number = {8},
doi = {10.1002/jgm.70031}
}
EUVIMED